News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
581,878 Results
Type
Article (20711)
Company Profile (319)
Press Release (560750)
Multimedia
Podcasts (111)
Webinars (15)
Section
Business (194351)
Career Advice (437)
Deals (29862)
Drug Delivery (51)
Drug Development (71600)
Employer Resources (39)
FDA (12262)
Job Trends (10556)
News (285478)
Policy (22176)
Tag
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (1234)
Accelerated approval (40)
ADA (38)
Adcomms (15)
Allergies (146)
Alliances (41171)
ALS (214)
Alzheimer's disease (1516)
Antibody-drug conjugate (ADC) (521)
Approvals (12830)
Artificial intelligence (568)
ASCO (272)
Autoimmune disease (338)
Automation (36)
Bankruptcy (299)
Best Places to Work (8508)
BIO (65)
BIOSECURE Act (6)
Biosimilars (174)
BioSpace Insights (80)
Biotechnology (227)
Bladder cancer (174)
Brain cancer (62)
Breast cancer (680)
Cancer (5489)
Cardiovascular disease (401)
Career advice (372)
Career pathing (13)
CAR-T (328)
CDC (9)
Celiac Disease (1)
Cell therapy (893)
Cervical cancer (43)
Clinical research (63702)
Collaboration (2011)
Commercialization (4)
Company closure (3)
Compensation (1493)
Complete response letters (74)
COVID-19 (1443)
CRISPR (122)
C-suite (1122)
Cystic fibrosis (142)
Data (7849)
Denatured (26)
Depression (163)
Dermatology (91)
Diabetes (496)
Diagnostics (4811)
Digital health (44)
Diversity (6)
Diversity, equity & inclusion (12)
Drug discovery (343)
Drug pricing (59)
Drug shortages (5)
Duchenne muscular dystrophy (318)
Earnings (80162)
Editorial (36)
Employer branding (6)
Employer resources (37)
Events (103237)
Executive appointments (980)
FDA (15723)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (24)
Frontotemporal dementia (35)
Funding (1631)
Gene editing (257)
Generative AI (41)
Gene therapy (717)
GLP-1 (692)
Government (1750)
Grass and pollen (4)
Guidances (336)
Healthcare (12014)
Hematology (148)
HIV (68)
Huntington's disease (62)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (105)
Immunology and inflammation (280)
Immuno-oncology (97)
Indications (203)
Infectious disease (1701)
Inflammatory bowel disease (205)
Inflation Reduction Act (12)
Influenza (93)
Intellectual property (302)
Interviews (58)
IPO (14361)
IRA (13)
Job creations (2423)
Job search strategy (335)
JPM (41)
Kidney cancer (20)
Labor market (35)
Layoffs (304)
Leadership (15)
Legal (5646)
Licensing (4)
Liver cancer (66)
Longevity (28)
Lung cancer (744)
Lymphoma (394)
Machine learning (46)
Management (9)
Manufacturing (817)
Marketing (11)
MASH (186)
Medical affairs (1)
Medical device (9904)
Medtech (10055)
Mergers & acquisitions (16692)
Metabolic disorders (1239)
mRNA (185)
Multiple sclerosis (158)
NASH (14)
Neurodegenerative disease (438)
Neuropsychiatric disorders (98)
Neuroscience (3017)
Neurotech (1)
NextGen: Class of 2026 (4134)
Non-profit (1520)
Now hiring (42)
Obesity (525)
Opinion (154)
Ovarian cancer (224)
Pain (230)
Pancreatic cancer (312)
Parkinson's disease (375)
Partnered (19)
Patents (574)
Patient recruitment (754)
Peanut (55)
People (49499)
Pharmaceutical (50)
Pharmacy benefit managers (13)
Phase 1 (21182)
Phase 2 (28692)
Phase 3 (19445)
Pipeline (9059)
Policy (116)
Postmarket research (1892)
Preclinical (8946)
Press Release (52)
Prostate cancer (289)
Psychedelics (71)
Radiopharmaceuticals (339)
Rare diseases (1107)
Real estate (3776)
Recruiting (14)
Regulatory (19397)
Reports (27)
Research institute (1322)
Resumes & cover letters (60)
Rett syndrome (46)
RNA editing (30)
RSV (57)
Schizophrenia (170)
Series A (302)
Series B (215)
Service/supplier (4)
Sickle cell disease (118)
Special edition (20)
Spinal muscular atrophy (143)
Sponsored (20)
Startups (3116)
State (1)
Stomach cancer (8)
Supply chain (73)
Tariffs (19)
The Weekly (83)
Vaccines (565)
Venture capital (102)
Weight loss (267)
Women's health (101)
Worklife (2)
Date
Today (79)
Last 7 days (482)
Last 30 days (1662)
Last 365 days (25942)
2026 (15362)
2025 (25847)
2024 (30087)
2023 (34045)
2022 (43431)
2021 (45823)
2020 (40953)
2019 (29906)
2018 (22507)
2017 (24238)
2016 (22693)
2015 (28921)
2014 (24898)
2013 (20699)
2012 (22517)
2011 (22781)
2010 (22445)
Location
Africa (337)
Alabama (91)
Alaska (3)
Arizona (331)
Arkansas (14)
Asia (28969)
Australia (4462)
California (13367)
Canada (3652)
China (1286)
Colorado (544)
Connecticut (518)
Delaware (363)
Europe (54226)
Florida (1949)
Georgia (404)
Hawaii (4)
Idaho (47)
Illinois (917)
India (76)
Indiana (434)
Iowa (15)
Japan (529)
Kansas (114)
Kentucky (36)
Louisiana (40)
Maine (36)
Maryland (1412)
Massachusetts (9710)
Michigan (311)
Minnesota (617)
Mississippi (5)
Missouri (93)
Montana (33)
Nebraska (14)
Nevada (128)
New Hampshire (75)
New Jersey (3134)
New Mexico (18)
New York (3309)
North Carolina (1641)
North Dakota (9)
Northern California (6816)
Ohio (336)
Oklahoma (15)
Oregon (35)
Pennsylvania (2630)
Puerto Rico (24)
Rhode Island (37)
South America (527)
South Carolina (76)
South Dakota (1)
Southern California (5317)
Tennessee (138)
Texas (2134)
United States (45367)
Utah (393)
Vermont (1)
Virginia (240)
Washington D.C. (51)
Washington State (1082)
West Virginia (2)
Wisconsin (107)
581,878 Results for "ascend therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Akagera Medicines Reports Positive First-in-Human Data for Single-Ascending-Dose of AKG-100, Advancing a Potentially Transformative Long-Acting Therapeutic for Drug-Resistant Tuberculosis
July 20, 2026
·
6 min read
Press Releases
TIXiMED Initiates Phase 1b Multiple Ascending Dose Study of TIX100
July 7, 2026
·
3 min read
Press Releases
Design Therapeutics Announces Initiation of Patient Dosing in Phase 1 Multiple Ascending Dose Trial of DT-818 for Myotonic Dystrophy Type-1
June 30, 2026
·
6 min read
Press Releases
Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAgo™ in Healthy Volunteers
June 8, 2026
·
8 min read
Press Releases
Ionis doses first participant in Phase 1-2 ASCEND study of ION337 in Dravet syndrome
July 13, 2026
·
5 min read
Press Releases
PureTech Founded Entity Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAgo™ in Healthy Volunteers
June 9, 2026
·
12 min read
Press Releases
Bambusa Therapeutics Presents Positive Preliminary Multiple Ascending Dose Phase 1 Data for BBT002 at the European Academy of Allergy & Clinical Immunology (EAACI) Annual Congress 2026
June 15, 2026
·
6 min read
Press Releases
Atisama Therapeutics Advances RB042 into Multiple Ascending Dose cohorts of Phase 1 Trial and Appoints Bernard Coulie as Chair of the Board
May 17, 2026
·
4 min read
Press Releases
Definium Therapeutics Announces First Patient Dosed in Ascend, the Second Phase 3 Pivotal Study of DT120 ODT in Major Depressive Disorder
May 12, 2026
·
10 min read
Press Releases
Syntis Bio Reports Positive Initial Phase 1/1b Single Ascending Dose Data for SYNT-101, Supporting its Novel Approach to Obesity Treatment
July 16, 2026
·
6 min read
1 of 58,188
Next
